Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04360954 · ClinicalTrials.gov registry record
Evaluation of Antibody Tests for COVID-19
A clinical trial of Coronavirus and COVID, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 461
- Enrollment target
- 1
- Study location
NCT04360954 is a study of Coronavirus and COVID that has completed, run by Washington University School of Medicine. The registered enrollment target is 461 participants, below the 1,382-participant average among 20 other Coronavirus trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04360954, a study of Coronavirus and COVID, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 461 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the sensitivity and specificity of several marketed commercial or prototype test kits for antibody to SARS-CoV-2. The focus will be on rapid-format, point-of-care antibody test kits that detect both IgM and IgG antibodies to recombinant viral proteins. Note: No voluntary enrolment into this study will be conducted; all testing is to be conducted anonymously.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Diagnostic test
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 461 participants |
| Start Date | 2020-04-23 |
| Est. Completion | 2020-07-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04360954
The ClinicalTrials.gov registry entry for NCT04360954 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 461 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,382-participant average among 20 other Coronavirus trials with a reported enrollment target (67% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Coronavirus appearing as the primary indexed condition, and to 1 intervention - of which Diagnostic test is the first listed.
NCT04360954 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT04360954 about?
NCT04360954 is a clinical study titled "Evaluation of Antibody Tests for COVID-19". The purpose of this study is to evaluate the sensitivity and specificity of several marketed commercial or prototype test kits for antibody to SARS-CoV-2. The focus will be on rapid-format, point-of-care antibody test kits that detect both IgM and IgG antibodies to recombinant viral proteins. Note:...
What is the current status of trial NCT04360954?
This trial is currently completed. The enrollment target is 461 participants. The study started on 2020-04-23. Estimated completion is 2020-07-08.
What conditions does trial NCT04360954 study?
This clinical trial studies the following conditions: Coronavirus, COVID.
What interventions are being tested in trial NCT04360954?
The interventions under investigation include: Diagnostic test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04360954?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04360954 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronavirus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses
RECRUITING
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Convalescent Plasma Collection and Treatment in Pediatrics and Adults
RECRUITING · Phase 3
-
ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
RECRUITING
-
A Study to Explore the Role of Gut Flora in COVID-19 Infection
RECRUITING
-
Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.